K Pharma

4896.TTSE GROWTHPharmaceutical

Filed as K Pharma, Inc. (2023-11–2026-08)

In English · 6

Mon, Apr 13 · JST1 filing

16:305% STAKEK Pharma · Hideyuki Okano · 11.05% → 10.03%−1.02pp

Fri, Feb 20 · JST1 filing

16:00MATERIALK Pharma · Change of independent auditor

Fri, Apr 4 · JST1 filing

16:205% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 17.08% → 15.10%−1.98pp

Thu, Apr 3 · JST1 filing

16:045% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 19.14% → 17.08%−2.06pp

Wed, Apr 2 · JST1 filing

16:265% STAKEK Pharma · SBI Ventures Two Co., Ltd. + 2 joint holders · 20.68% → 19.14%−1.54pp

Mon, Mar 31 · JST1 filing

16:265% STAKEK Pharma · ITOCHU Technology Ventures, Inc. · 5.13% → 2.02%−3.11pp

All EDINET filings · 45

All Financial 8 5% 19 Material 3 Other 15

Filed	Document	Filer	Source
2026-03-30	Material event report	K Pharma, Inc.	S100XVIS
2026-02-20	Material event report	K Pharma, Inc.	S100XMJ7
2025-03-28	Material event report	K Pharma, Inc.	S100VIBE

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected.